Showing results (1-10 of 7) with videos related to
Sort By:
Pageof 1
Clinical Pharmacokinetics|May 25, 2006
Exploring the relationship between expression of cytochrome P450 enzymes and gefitinib pharmacokineticsHelen C Swaisland, Mireille V Cantarini, Rainard Fuhr, et al.Pulmonary Pharmacology & Therapeutics|February 7, 2012
Effects of an oral MMP-9 and -12 inhibitor, AZD1236, on biomarkers in moderate/severe COPD: a randomised controlled trialRonald Dahl, Ingrid Titlestad, Ari Lindqvist, et al.Nature Reviews. Drug Discovery|November 21, 2015
Pioneering government-sponsored drug repositioning collaborations: progress and learningDonald E Frail, Madeleine Brady, K Jane Escott, et al.Cancer Chemotherapy and Pharmacology|April 14, 2011
The effect of different etiologies of hepatic impairment on the pharmacokinetics of gefitinibJiri Horak, Jeff White, Adrian L Harris, et al.The Journal of Investigative Dermatology|February 16, 2016
Use of a Canine Model of Atopic Dermatitis to Investigate the Efficacy of a CCR4 Antagonist in Allergen-Induced Skin Inflammation in a Randomized StudyClare Murray, Kim Ahrens, Matt Devalaraja, et al.Pulmonary Pharmacology & Therapeutics|September 27, 2021
Effect of centrally and peripherally acting GABA<sub>B</sub> agonism on the healthy human cough reflexHuda Badri, Carmen LGibbard, Dimitra Denton, et al.ERJ Open Research|March 17, 2022
A double-blind randomised placebo-controlled trial investigating the effects of lesogaberan on the objective cough frequency and capsaicin-evoked coughs in patients with refractory chronic coughHuda Badri, Carmen Gibbard, Dimitra Denton, et al.Pageof 1